SCHEMBL7964624

SCHEMBL7964624

c1cc2c(cc1OC[C@@H]1CO1)CCCC2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.59
TSHR P16473 4/20 0.59
TP53 P04637 4/20 0.59
SMN1; SMN2 Q16637 4/20 0.59
HIF1A Q16665 2/20 0.59
CYP3A4 P08684 1/20 0.59
PKM P14618 2/20 0.53
LMNA P02545 1/20 0.53
GAA P10253 1/20 0.53
TDP1 Q9NUW8 1/20 0.51
HSD17B10 Q99714 2/20 0.51
ALOX15 P16050 1/20 0.51
MAPT P10636 5/20 0.49
HPGD P15428 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
PPARG P37231 2/20 0.49
CYP1A2 P05177 1/20 0.49
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3133660 1.00 ALDH1A1 (0.59) ALDH1A1TSHRTP53SMN1; SMN2HIF1A
SCHEMBL7964625 1.00 ALDH1A1 (0.59) ALDH1A1TSHRTP53SMN1; SMN2HIF1A
SCHEMBL3142670 0.97 SMN1; SMN2 (0.59) ALDH1A1TSHRTP53SMN1; SMN2HIF1A
SCHEMBL1495909 0.80 GRM2 (0.50) ALDH1A1TSHRTP53SMN1; SMN2HIF1A
SCHEMBL1495907 0.80 GRM2 (0.50) ALDH1A1TSHRTP53SMN1; SMN2HIF1A
SCHEMBL7777400 0.79 MAOB (0.58) ALDH1A1TSHRTP53SMN1; SMN2HIF1A
SCHEMBL11875425 0.79 ALDH1A1 (0.49) ALDH1A1TSHRTP53SMN1; SMN2HIF1A
SCHEMBL1715242 0.78 ALDH1A1 (0.71) ALDH1A1TSHRTP53SMN1; SMN2HIF1A
SCHEMBL20677146 0.78 TDP1 (0.79) ALDH1A1TSHRTP53SMN1; SMN2HIF1A
SCHEMBL21094081 0.78 TDP1 (0.79) ALDH1A1TSHRTP53SMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed